SCHEMBL6638341

SCHEMBL6638341

Clc1ccnc(SCc2ccc3ccccc3c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
DAO P14920 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ROCK1 Q13464 1/20 0.41
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
GSK3A P49840 1/20 0.40
MAPK10 P53779 1/20 0.40
RIOK2 Q9BVS4 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7509985 0.83 HSD17B10 (0.65) MAPK1HSD17B10CYP1A2CYP3A4CYP2C9
SCHEMBL9092866 0.82 DAO (0.49) MAPK1HSD17B10CYP1A2CYP3A4CYP2C9
SCHEMBL6638021 0.82 RAB9A (0.50) MAPK1HSD17B10CYP1A2CYP3A4CYP2C9
SCHEMBL6642336 0.79 CYP1A2 (0.46) MAPK1HSD17B10CYP1A2CYP3A4CYP2C9
SCHEMBL6639242 0.78 MEN1 (0.57) MAPK1DAOL3MBTL1NPC1RAB9A
SCHEMBL27595525 0.77 MAPT (0.50) MAPK1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL6675170 0.76 MAPT (0.50) MAPK1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6391680 0.75 CYP1A2 (0.43) MAPK1HSD17B10CYP1A2CYP3A4CYP2C9
SCHEMBL6638339 0.75 NPC1 (0.42) MAPK1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL27840909 0.74 CTSB (0.52) CYP1A2CYP3A4CYP2C19L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824524-B1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE UPJOHN CO (US) 2004-09-08 EP disclosed
EP-1449835-A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds PHARMACIA & UPJOHN COMPANY (US) 2004-08-25 EP disclosed
EP-1247804-A1 Pyrimidine-thioalkyl and alkylether compounds PHARMACIA & UPJOHN COMPANY (US) 2002-10-09 EP disclosed
US-6043248-A VIRICIDES FOR TREATING AN INDIVIDUAL INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS PHARMACIA & UPJOHN COMPANY (US) 2000-03-28 US disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 EP disclosed
WO-1996035678-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1996-11-14 WO disclosed